What is AroCell AB (publ) (AROC.ST)?

AroCell AB (publ) (AROC.ST) is a stock in the Healthcare sector, Medical - Diagnostics & Research industry. View full analysis on Stocks360.

AroCell AB (publ) (AROC.ST)

Stock analysis · STO · Healthcare · Medical - Diagnostics & Research

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

1.21

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

AroCell AB (publ) (AROC.ST) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About AroCell AB (publ)

AroCell AB (publ) is an in vitro diagnostics enterprise primarily focused on the surveillance of various cancerous conditions, such as hematological malignancies, breast cancer, and other solid tumors. The company develops, produces, and markets its flagship product, AroCell TK 210 ELISA, an immunoassay kit designed for measuring Thymidine Kinase 1 levels in human blood. Additionally, AroCell provides TUBEX TF, a rapid bacteriological test for the detection of typhoid fever. Founded in 2000, the firm was originally known as Xi Bao Research AB, adopting its current name, AroCell AB (publ), in 2006. It maintains its headquarters in Uppsala, Sweden.